This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

Brain function has traditionally been interpreted within a neuron-centric framework; however, this view has shifted toward a model of neuron-glia ...

Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.